Nihon M&A Center (2127) Q4 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2026 earnings summary
30 Apr, 2026Executive summary
Celebrated 35th anniversary and marked a full recovery from the FY 2021 accounting incident, entering a new growth phase called Next GENESIS and launching "Vision 300" targeting ¥30bn ordinary profit by FY2032.
Achieved strong recovery in FY2025 with net sales up 14.0% YoY to ¥50,257 million and ordinary profit up 13.2% YoY to ¥19,154 million, surpassing mid-term targets a year early.
Regained original performance cycle, with improved departmental budget achievement rates and a focus on mandates with higher closing likelihood.
Introduced a trust-type stock compensation plan to align interests of employees, executives, and investors.
Batonz, an equity-method affiliate, listed on TSE Growth segment, reflecting strong market expectations.
Financial highlights
Sales: ¥50,257 million (+14.0% YoY); ordinary profit: ¥19,154 million (+13.2% YoY); net profit: ¥12,515 million (+14.1% YoY).
Number of transactions closed: 1,061 (-1.6% YoY); M&A sales per transaction: ¥45.7 million (+15.4% YoY); large transactions closed increased by 45.6%.
Gross profit margin: 60.2%; ordinary profit margin: 38.1% (down 0.3pt YoY); ROE remained above 20%.
Net assets: ¥50,643 million; total assets: ¥66,223 million; equity-to-asset ratio stood at 75.8%.
Basic earnings per share increased to ¥39.36; annual dividend per share was ¥29.00, including a special dividend.
Outlook and guidance
FY2026/FY2027 guidance: sales ¥52,800 million (+5.1% YoY), ordinary profit ¥19,300 million (+0.8% YoY), net profit ¥13,400 million (+7.3% YoY).
Vision 300 aims for ordinary profit of ¥30 billion by FY2032, with business domain expansion in funds, overseas, and PMI.
Dividend per share forecast for FY2027 is ¥29.00, including a special dividend; payout ratio to remain above 60%.
Ordinary profit margin expected to decline slightly due to increased investment in HR, IT, and branding.
Latest events from Nihon M&A Center
- Sales and profit fell, but record new mandates and strong forecasts signal future growth.2127
Q3 20253 Feb 2026 - Record new mandates and strong profit margins support growth despite industry challenges.2127
Q2 20253 Feb 2026 - Q1 sales and profits fell, but strong mandates and investments support a positive outlook.2127
Q1 20252 Feb 2026 - Record sales, profits, and margins drive positive outlook and special dividend.2127
Q3 20262 Feb 2026 - Record Q4 profit, cautious outlook, focus on quality, compliance, and new growth pillars.2127
Q4 202529 Nov 2025 - Q1 sales and profits surged, margins improved, and guidance remains strong with a special dividend.2127
Q1 202616 Nov 2025 - H1 FY2025 saw strong profit and sales growth, margin gains, and a special dividend planned.2127
Q2 20263 Nov 2025